MAHIDOL UNIVERSITY
🇹ðŸ‡Thailand
- Country
- 🇹ðŸ‡Thailand
- Ownership
- Private
- Established
- 1888-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://mahidol.ac.th
SGLT2 Inhibitors Show Promise in Managing Chronic Kidney Disease in Real-World Settings
A recent study highlights the effectiveness and safety of sodium-glucose co-transporter 2 inhibitors (SGLT2i) in managing chronic kidney disease (CKD), showing a significant reduction in the risk of major adverse kidney events (MAKEs) compared to traditional RAAS blockade therapy. The study, conducted in a real-world setting, supports the broader application of SGLT2i in CKD management, regardless of diabetic status, aligning with the 2024 KDIGO guidelines.
© Copyright 2025. All Rights Reserved by MedPath